Loading...
PhD Alja Štern

PhD Alja Štern
no.: 32094 source: ARIS

researcher – active in research organisation
  alja.sternat signnib.si
Foreign language skills
Research activity

Code Science Field Subfield
1.08.00  Natural sciences and mathematics  Control and care of the environment   
4.06.00  Biotechnical sciences  Biotechnology   
Keywords
genetic toxicology, chemoprotective substances, advanced in vitro test systems, epigenetics, nanomaterials
Points
433.75
A''
96.09
A'
253.65
A1/2
264.14
CI10
707
CImax
223
h10
15
A1
1.57
A3
0.58
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2020, 2021, 2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 28  823  728  26 
Scopus 29  939  828  28.55 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Biotechnical Faculty 2008 
Doctoral degree  Ph. D.   Genetics  SI University of Ljubljana, Biotechnical Faculty 2013 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  National Institute of Biology  Department of Genetic Toxicology and Cancer Biology  10/1/2019  Research associate  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J7-60117  Degradation of Cyanotoxins Through Cold Plasma Technologies and Toxicological Characterisation of Transformation Products (CyanoCAPtox)   1/1/2025 - 12/31/2027  PhD Martina Štampar   1,961 
2. J1-60016  Mycotoxins and their complex mixtures: relevance for human health hazard from contaminated food   1/1/2025 - 12/31/2027  PhD Matjaž Novak   2,970 
3. BI-HR/25-27-014  Multibiomarker approach in evaluating air pollution in vitro (MULTIap)   1/1/2025 - 12/31/2026  PhD Alja Štern   94 
4. J4-50147  Exploring the theranostic potential of aegerolysin-based protein complexes in combating bladder cancer   10/1/2023 - 9/30/2026  PhD Kristina Sepčić   4,045 
5. J2-50047  Plasma-assisted removal of emerging genotoxic contaminants from wastewater   10/1/2023 - 9/30/2026  PhD Martina Modic   2,735 
6. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,640 
7. J1-4395  Development of novel multifunctional metal-oxide-based nanozymes and their toxicological characterisation (NaNoZymSafe)   10/1/2022 - 9/30/2025  PhD Bojana Žegura   2,900 
8. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors   10/1/2022 - 9/30/2025  PhD Andrej Perdih   2,881 
9. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour   10/1/2021 - 12/31/2024  PhD Alja Štern   5,119 
10. J1-2471  Chemical Carcinogenesis: Mechanistic Insights   9/1/2020 - 8/31/2024  PhD Urban Bren   6,889 
11. J1-2465  Advanced 3D cell models: Bridging the gap between in vitro and in vivo experimental systems (hep3DGenTox)   9/1/2020 - 12/31/2023  PhD Bojana Žegura   3,403 
12. J4-1770  Plasma decontamination of mycotoxins and inactivation of fungi in food industry   7/1/2019 - 6/30/2022  PhD Martina Modic   2,279 
13. L4-9325  Development of new, environment-friendly approaches for plant and human virus inactivation in waters   7/1/2018 - 6/30/2022  PhD Maja Ravnikar   7,070 
14. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   7/1/2018 - 6/30/2021  PhD Lucija Peterlin Mašič   2,420 
15. J1-8140  Endokrini in genotoksični potencial inhibitorjev proteinskih kinaz: pomen za tveganja za okolje in zdravje ljudi (Slovene)   5/1/2017 - 4/30/2020  PhD Metka Filipič   4,032 
16. J3-4259  Priprava in validacija terapevtskih plazmidov brez selekcijskega gena za antibiotično rezistenco za gensko terapijo raka z inducibilnimi in tkivno specifičnimi promotorji (Slovene)   7/1/2011 - 6/30/2014  PhD Maja Čemažar   6,296 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   1/1/2019 - 12/31/2027 PhD Bojana Žegura   3,065 
2. P1-0245  Ekotoksiologija, toksikološka genomika in karcinogeneza (Slovene)   1/1/2009 - 12/31/2014 PhD Tamara Lah Turnšek   3,476 
Biography
Alja Štern graduated in Microbiology at the Biotechnical Faculty of the University of Ljubljana in September 2008. In October 2008 she enrolled in the doctoral study of Biological and Biotechnological Sciences at the Biotechnical Faculty of the University of Ljubljana, majoring in genetics. In October 2009 she became a young researcher at the National Institute of Biology (NIB) in Ljubljana, Department of Genetic Toxicology and Cancer Biology. She completed her PhD in 2013. From April 2013 to October 2019, Alja Štern was employed at Lek d.d. as researcher / researcher-expert at the department MS&T Laboratory, working in the field bioprocesses development and optimization, for the production of microbial secondary metabolites. Since 01.10.2019 she is employed at the National Institute of Biology in Ljubljana, at the Department of Genetic Toxicology and Cancer Biology as a research assistant.
Views history
Favourite